Heart and Vessels

, Volume 31, Issue 10, pp 1724–1730 | Cite as

Association of resistin with impaired membrane fluidity of red blood cells in hypertensive and normotensive men: an electron paramagnetic resonance study

  • Kazushi Tsuda
Short Communication


Abnormalities in physical properties of the cell membranes may strongly be linked to hypertension. Recent evidence indicates that resistin may actively participate in the pathophysiology of insulin resistance, diabetes mellitus, hypertension and other circulatory disorders. The present study was undertaken to investigate the possible relationships among plasma resistin, oxidative stress and membrane fluidity (a reciprocal value of membrane microviscosity) in hypertension. We measured the membrane fluidity of red blood cells (RBCs) in hypertensive and normotensive men using an electron paramagnetic resonance (EPR) and spin-labeling method. The order parameter (S) for the spin-label agents (5-nitroxide stearate) in EPR spectra of red blood cell (RBC) membranes was significantly higher in hypertensive men than in normotensive men, indicating that membrane fluidity was decreased in hypertension. Plasma resistin levels were correlated with systolic blood pressure and 8-iso-prostaglandin F2α levels (an index of oxidative stress). Furthermore, the order parameter (S) of RBCs significantly correlated with plasma resistin and plasma 8-isoPG F2α, suggesting that reduced membrane fluidity of RBCs might be associated with hyperresistinemia and increased oxidative stress. Multivariate regression analysis showed that, after adjustment for confounding factors, plasma resistin might be an independent determinant of membrane fluidity of RBCs. The EPR study suggests that resistin might have a close correlation with impaired rheologic behavior of RBCs and microcirculatory dysfunction in hypertension, at least in part, via an oxidative stress-dependent mechanism.


Resistin Oxidative stress Membrane fluidity Red blood cells Electron spin resonance Hypertension 



This study was supported in part by grants-in-aid for scientific research from the Ministry of Education, Science, Sports, Culture and Technology of Japan (20590710, 23590901, 26460926). A part of this study was presented at the 77th Annual Scientific Meeting of the Japanese Society of Circulation at Yokohama, Japan in 2013, and an abstract has been published in Circulation Journal (2013;77(suppl I):I-589).

Compliance with ethical standards

Conflict of interest

The author declared no conflicts of interest.


  1. 1.
    Steppan CM, Bailey ST, Bhat S, Brown EJ, Banergee RR, Wright CM, Patel HR, Ahima RS, Lazar MA (2001) The hormone resistin links obesity to diabetes. Nature 409:307–312CrossRefPubMedGoogle Scholar
  2. 2.
    Lee SE, Kim HS (2012) Human resistin and cardiovascular disease. J Smooth Muscle Res 48:27–35CrossRefPubMedGoogle Scholar
  3. 3.
    Steppan CM, Lazar MA (2004) The current biology of resistin. J Intern Med 255:439–447CrossRefPubMedGoogle Scholar
  4. 4.
    Lazar MA (2007) Resistin- and obesity-associated metabolic diseases. Horm Metab Res 39:710–716CrossRefPubMedGoogle Scholar
  5. 5.
    Tsioufis C, Dimitriadis K, Selima M, Miliou A, Toutouzas K, Roussos D, Stefanadi E, Tousoulis D, Kallikazaros I, Stefanadis C (2010) Association of resistin with urinary albumin excretion in nondiabetic patients with essential hypertension. Am J Hypertens 23:681–686CrossRefPubMedGoogle Scholar
  6. 6.
    Ellington AA, Malik AR, Klee GG, Turner ST, Rule AD, Mosley TH, Kullo I (2007) Association of plasma resistin with glomerular filtration rate and albuminuria in hypertensive adults. Hypertension 50:708–714CrossRefPubMedGoogle Scholar
  7. 7.
    Ohmori R, Moriyama Y, Kato R, Taniguchi H, Ogura M, Ayaori M, Nakamura H, Ohsuzu F (2005) Associations between serum resistin levels and insulin resistance, inflammation, and coronary artery disease. J Am Coll Cardiol 46:379–380CrossRefPubMedGoogle Scholar
  8. 8.
    On YK, Park HK, Hyon MS, Jeon ES (2007) Serum resistin as a biological marker for coronary artery disease and restenosis in type 2 diabetic patients. Circ J 71:868–873CrossRefPubMedGoogle Scholar
  9. 9.
    Weikert C, Westphal S, Berger K, Dierkes J, Mohlig M, Spranger J, Rimm EB, Willich SN, Boeing H, Pischon T (2008) Plasma resisitin levels and risk of myocardial infarction and ischemic stroke. J Clin Endocrinol Metab 93:2647–2653CrossRefPubMedGoogle Scholar
  10. 10.
    Heistad DD, Wakisaka Y, Miller J, Chu Y, Pena-Silva R (2009) Novel aspects of oxidative stress in cardiovascular diseases. Circ J 73:201–207CrossRefPubMedGoogle Scholar
  11. 11.
    Schulz E, Gori T, Munzel T (2011) Oxidative stress and endothelial dysfunction in hypertension. Hypertens Res 34:665–673CrossRefPubMedGoogle Scholar
  12. 12.
    Whaley-Connell A, McCullough PA, Sowers JR (2011) The oxidative stress in the metabolic syndrome. Rev Cardiovasc Med 12:21–29PubMedGoogle Scholar
  13. 13.
    Pu Q, Neves MF, Virdis A, Touyz RM, Schiffrin EL (2003) Endothelin antagonism on aldosterone-induced oxidative stress and vascular remodeling. Hypertension 42:49–55CrossRefPubMedGoogle Scholar
  14. 14.
    Shida T, Nozawa T, Sobajima M, Ihori H, Matsuki A, Inoue H (2014) Fluvastatin-induced reduction of oxidative stress ameliorates diabetic cardiomyopathy in association with improving coronary microvasculature. Heart Vessels 29:532–541CrossRefPubMedGoogle Scholar
  15. 15.
    Wang X, Yuan B, Dong W, Yang B, Yang Y, Lin X, Gong G (2015) Humid heat exposure induced oxidative stress and apoptosis cardiomyocytes through the angiotensin II signaling pathway. Heart Vessels 30:396–405CrossRefPubMedGoogle Scholar
  16. 16.
    Dhawan V, Jain S (2004) Effect of garlic supplementation on oxidized low density lipoprotein and lipid peroxidation in patients of essential hypertension. Mol Cell Biochem 266:109–115CrossRefPubMedGoogle Scholar
  17. 17.
    Rodrigo R, Prat H, Passalacqua W, Araya J, Guichard C, Bachler JP (2007) Relationship between oxidative stress and essential hypertension. Hypertens Res 30:1159–1167CrossRefPubMedGoogle Scholar
  18. 18.
    Vassalle C, Botto N, Andreassi MG, Berti S, Biagini A (2003) Evidence for enhanced 8-isoprostane plasma levels, as index of oxidative stress in vivo, in patients with coronary artery disease. Coron Artery Dis 14:213–218PubMedGoogle Scholar
  19. 19.
    Wang B, Pan J, Wang L, Zhu H, Yu R, Zou Y (2006) Association of plasma 8-isoprostane levels with the presence and extent of coronary stenosis in patients with coronary artery disease. Atherosclerosis 184:425–430CrossRefPubMedGoogle Scholar
  20. 20.
    Tsuda K (2010) Oxidative stress and membrane fluidity of red blood cells in hypertensive and normotensive men: an electron spin resonance investigation. Int Heart J 51:121–124CrossRefPubMedGoogle Scholar
  21. 21.
    Tsuda K, Nishio I (2003) Membrane fluidity and hypertension. Am J Hypertens 16:259–261CrossRefPubMedGoogle Scholar
  22. 22.
    Zicha J, Kunes J, Devynck MA (1999) Abnormalities of membrane function and lipid metabolism in hypertension. Am J Hypertens 12:315–331CrossRefPubMedGoogle Scholar
  23. 23.
    Tsuda K, Iwahashi H, Minatogawa Y, Nishio I, Kido R, Masuyama Y (1987) Electron spin resonance studies of erythrocytes from spontaneously hypertensive rats and humans with essential hypertension. Hypertension 9(6 Pt 2):III-19–III-24Google Scholar
  24. 24.
    Tsuda K, Kimura K, Nishio I (2002) Leptin improves membrane fluidity of erythrocytes in humans via a nitric oxide-dependent mechanism -an electron paramagnetic resonance investigation. Biochem Biophys Res Commun 297:672–681CrossRefPubMedGoogle Scholar
  25. 25.
    Tsuda K (2006) Adiponectin and membrane fluidity of erythrocytes in normotensive and hypertensive men. Obesity 14:1505–1510CrossRefPubMedGoogle Scholar
  26. 26.
    Tsuda K, Kimura K, Nishio I, Masuyama Y (2000) Nitric oxide improves membrane fluidity of erythrocytes in essential hypertension -an electron paramagnetic resonance investigation-. Biochem Biophys Res Commun 275:946–954CrossRefPubMedGoogle Scholar
  27. 27.
    Tsuda K, Kinoshita Y, Kimura K, Nishio I, Masuyama Y (2001) Electron paramagnetic resonance investigation on modulatory effect of 17β-estradiol on membrane fluidity of erythrocytes in postmenopausal women. Arterioscler Thromb Vasc Biol 21:1306–1312CrossRefPubMedGoogle Scholar
  28. 28.
    Tsuda K (2008) Electron paramagnetic resonance investigation on modulatory effect of benidipine on membrane fluidity of erythrocytes in essential hypertension. Heart Vessels 23:134–139CrossRefPubMedGoogle Scholar
  29. 29.
    Tsuda K (2013) Chronic kidney disease predicts impaired membrane microviscosity of red blood cells in hypertensive and normotensive subjects: an electron spin resonance study. Int Heart J 54:154–159CrossRefPubMedGoogle Scholar
  30. 30.
    Sato B, Nishikida K, Samuels LT, Tyler FH (1978) Electron spin resonance studies of erythrocytes from patients with Duchenne muscular dystrophy. J Clin Invest 61:251–259CrossRefPubMedPubMedCentralGoogle Scholar
  31. 31.
    Le Sang Quan KH, Levenson J, Del Pino M, Simon A, Devynck MA (1993) In vivo shear flow and erythrocytes membrane fluidity in hypertensive patients. Br J Clin Pharmacol 36:437–443CrossRefPubMedPubMedCentralGoogle Scholar
  32. 32.
    Saldanha C, Sargento L, Monteiro J, Perdigao C, Ribeiro C, Martins-Silva J (1999) Impairement of the erythrocyte membrane fluidity in survivors of acute myocardial infarction. A prospective study. Clin Hemorheol Microcirc 20:111–116PubMedGoogle Scholar
  33. 33.
    Cazzola R, Rondanelli M, Russo-Volpe S, Ferrari E, Cestaro B (2004) Decreased membrane fluidity and altered susceptibility to peroxidation and lipid composition in overweight and obese female erythrocytes. J Lipid Res 45:1846–1851CrossRefPubMedGoogle Scholar
  34. 34.
    Shyu KG, Lien LM, Wang BW, Kuan P, Chang H (2011) Resistin contributes to neointimal formation via oxidative stress after vascular injury. Clin Sci 120:121–129CrossRefPubMedGoogle Scholar
  35. 35.
    Chen C, Jiang J, Lu JM, Chai H, Wang X, Lin PH, Yao Q (2010) Resistin decreases expression of endothelial nitric oxide synthase through oxidative stress in human coronary artery endothelial cells. Am J Physiol Heart Circ Physiol 299:H193–H201CrossRefPubMedPubMedCentralGoogle Scholar
  36. 36.
    Annuk M, Zilmer M, Lind L, Linde T, Fellstrom B (2001) Oxidative stress and endothelial function in chronic renal failure. J Am Soc Nephrol 12:2747–2752PubMedGoogle Scholar

Copyright information

© Springer Japan 2015

Authors and Affiliations

  1. 1.Cardiovascular Medicine, Cardiovascular and Metabolic Research CenterKansai University of Health SciencesOsakaJapan
  2. 2.Division of Cardiology, School of MedicineWakayama Medical UniversityWakayamaJapan

Personalised recommendations